# Omega 3 for Treatment of Depression in Patients With Heart Failure

> **NCT02057406** · PHASE3 · COMPLETED · sponsor: **Wei Jiang** · enrollment: 108 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** 2:1 EPA/DHA
- **DRUG:** High EPA
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02057406
- **Lead sponsor:** Wei Jiang
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2016-05-19
- **Final completion:** 2016-12-02
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2018-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02057406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02057406, "Omega 3 for Treatment of Depression in Patients With Heart Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02057406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*